Provided by Tiger Trade Technology Pte. Ltd.

LMP Capital and Income Fund Inc

14.88
+0.16001.09%
Post-market: 14.880.00000.00%16:10 EDT
Volume:63.67K
Turnover:940.35K
Market Cap:340.12M
PE:5.30
High:14.88
Open:14.73
Low:14.71
Close:14.72
52wk High:16.18
52wk Low:13.79
Shares:22.86M
Float Shares:22.86M
Volume Ratio:0.92
T/O Rate:0.28%
Dividend:1.44
Dividend Rate:9.68%
EPS(TTM):2.81
EPS(LYR):-0.0358
ROE:19.14%
ROA:1.15%
PB:0.86
PE(LYR):-415.57

Loading ...

FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition

GlobeNewswire
·
Oct 07

SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds

GlobeNewswire
·
Oct 05

SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026

GlobeNewswire
·
Oct 02

New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical’s SCD Therapy for Acute Kidney Injury (AKI)

GlobeNewswire
·
Oct 01

SeaStar Medical Congratulates H. David Humes, M.D., on Receiving the University of Michigan 2026 Distinguished University Innovator of the Year for Development of the SCD Therapy

GlobeNewswire
·
Sep 24

LMP Capital and Income Fund Says Senior Vice President Ann Elizabeth Doyle Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Franklin Templeton Funds Pay August Distributions, BWG at $0.08 Per Share

Reuters
·
Aug 31

Press Release: SeaStar Medical Reports Second Quarter 2026 Financial Results and Provides Business Updates

Dow Jones
·
Aug 13

Press Release: Cryoport Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 07

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

GlobeNewswire
·
Aug 06

Press Release: Franklin Templeton Announces Distributions for Certain Closed-End Funds Pursuant to Their Managed Distribution Policy for the Months of September, October and November 2026

Dow Jones
·
Aug 05

LMP Capital and Income Fund Declares $0.12 Monthly Distributions for September-November 2026

Reuters
·
Aug 05

Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD)

GlobeNewswire
·
Aug 04

Press Release: Disc Medicine Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Jul 30

Press Release: Oryzon Reports Financial Results and Corporate Update for Half Year Ended June 30th, 2026

Dow Jones
·
Jul 28

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

GlobeNewswire
·
Jul 14

Franklin Templeton Posts June Distributions for Five Closed-end Funds, Including BWG at $0.08 Per Share

Reuters
·
Jun 30

IBM, Verizon, Corning And A Health Care Stock On CNBC’s ‘Final Trades’

Benzinga
·
Jun 30

SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury

GlobeNewswire
·
Jun 23

SeaStar Medical to Present at Upcoming Investor Summit Conference

GlobeNewswire
·
Jun 22